Therapy and Monitoring

The 5-year survival rate for people with cancerous brain or CNS tumors is 34 percent for men and 36 percent for women.⁷ GE Healthcare’s technology helps to improve visualization and analytical monitoring of disease progression or response to therapy.⁸

Products

SIGNA™ PET/MR with QuantWorks – 60cm
Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with innovative Q.Clear reconstruction delivers 2x improvement in image quality. In addition, SIGNA PET/MR with QuantWorks includes a comprehensive suite of applications and flexible research tools to pursue ideas that could influence the future of medicine
OncoQuant
Robust tools for routine Oncology diagnosis, treatment follow-up, reporting and clinical trial management.
CT Perfusion 4D Neuro
Complete assessment. Confident treatment. Quick, automatic tissue assessment. Easy-to-use, protocol-driven workflow. Smart Map for exquisite functional images. All the information you need. Now.

7. https://www.cancer.net/cancer-types/brain-tumor/statistics
8. https://www.gehealthcare.com/en/products/advanced-visualization/all-applications/pet-vcar

Therapy and Monitoring

Therapy and Monitoring

Products

SIGNA™ PET/MR with QuantWorks – 60cm

OncoQuant

CT Perfusion 4D Neuro